LINK ALTERNATIF MBL77 - AN OVERVIEW

Not all individuals with CLL need therapy. In spite of all latest developments, the iwCLL nevertheless recommends watchful observation for patients with asymptomatic disease.86 This advice is predicated on at the least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FC